These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9748528)

  • 1. Systemic d-amphetamine administration causes a reduction of kynurenic acid levels in rat brain.
    Rassoulpour A; Wu HQ; Poeggeler B; Schwarcz R
    Brain Res; 1998 Aug; 802(1-2):111-8. PubMed ID: 9748528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia.
    Olsson SK; Andersson AS; Linderholm KR; Holtze M; Nilsson-Todd LK; Schwieler L; Olsson E; Larsson K; Engberg G; Erhardt S
    Int J Neuropsychopharmacol; 2009 May; 12(4):501-12. PubMed ID: 18796185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous kynurenic acid regulates extracellular GABA levels in the rat prefrontal cortex.
    Beggiato S; Tanganelli S; Fuxe K; Antonelli T; Schwarcz R; Ferraro L
    Neuropharmacology; 2014 Jul; 82():11-8. PubMed ID: 24607890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation and function of kynurenic acid in the immature rat brain.
    Schwarcz R; Ceresoli-Borroni G; Wu HQ; Rassoulpour A; Poeggeler B; Hodgkins PS; Guidetti P
    Adv Exp Med Biol; 1999; 467():113-23. PubMed ID: 10721048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrical kindling is associated with a lasting increase in the extracellular levels of kynurenic acid in the rat hippocampus.
    Wu HQ; Monno A; Schwarcz R; Vezzani A
    Neurosci Lett; 1995 Sep; 198(2):91-4. PubMed ID: 8592649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kynurenate production by cultured human astrocytes.
    Kiss C; Ceresoli-Borroni G; Guidetti P; Zielke CL; Zielke HR; Schwarcz R
    J Neural Transm (Vienna); 2003 Jan; 110(1):1-14. PubMed ID: 12541009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged nicotine administration results in biphasic, brain-specific changes in kynurenate levels in the rat.
    Rassoulpour A; Wu HQ; Albuquerque EX; Schwarcz R
    Neuropsychopharmacology; 2005 Apr; 30(4):697-704. PubMed ID: 15496939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain.
    Ceresoli-Borroni G; Rassoulpour A; Wu HQ; Guidetti P; Schwarcz R
    J Neural Transm (Vienna); 2006 Oct; 113(10):1355-65. PubMed ID: 16465454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain?
    Wu HQ; Rassoulpour A; Schwarcz R
    J Neural Transm (Vienna); 2007 Jan; 114(1):33-41. PubMed ID: 16932989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Large Neutral Amino Acid Transporters Suppresses Kynurenic Acid Production Via Inhibition of Kynurenine Uptake in Rodent Brain.
    Sekine A; Kuroki Y; Urata T; Mori N; Fukuwatari T
    Neurochem Res; 2016 Sep; 41(9):2256-66. PubMed ID: 27161376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astrocyte-derived kynurenic acid modulates basal and evoked cortical acetylcholine release.
    Zmarowski A; Wu HQ; Brooks JM; Potter MC; Pellicciari R; Schwarcz R; Bruno JP
    Eur J Neurosci; 2009 Feb; 29(3):529-38. PubMed ID: 19187269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The astrocyte-derived alpha7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex.
    Wu HQ; Pereira EF; Bruno JP; Pellicciari R; Albuquerque EX; Schwarcz R
    J Mol Neurosci; 2010 Jan; 40(1-2):204-10. PubMed ID: 19690987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid.
    Luchowska E; Luchowski P; Paczek R; Ziembowicz A; Kocki T; Turski WA; Wielosz M; Lazarewicz J; Urbanska EM
    J Neurosci Res; 2005 Feb; 79(3):375-82. PubMed ID: 15605380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subchronic elevation of brain kynurenic acid augments amphetamine-induced locomotor response in mice.
    Olsson SK; Larsson MK; Erhardt S
    J Neural Transm (Vienna); 2012 Feb; 119(2):155-63. PubMed ID: 21904895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term systemic administration of kynurenic acid brain region specifically elevates the abundance of functional CB
    Zádor F; Nagy-Grócz G; Dvorácskó S; Bohár Z; Cseh EK; Zádori D; Párdutz Á; Szűcs E; Tömböly C; Borsodi A; Benyhe S; Vécsei L
    Neurochem Int; 2020 Sep; 138():104752. PubMed ID: 32445659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortical kynurenic acid bi-directionally modulates prefrontal glutamate levels as assessed by microdialysis and rapid electrochemistry.
    Konradsson-Geuken A; Wu HQ; Gash CR; Alexander KS; Campbell A; Sozeri Y; Pellicciari R; Schwarcz R; Bruno JP
    Neuroscience; 2010 Sep; 169(4):1848-59. PubMed ID: 20600676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymatic transamination of D-kynurenine generates kynurenic acid in rat and human brain.
    Pérez-de la Cruz V; Amori L; Sathyasaikumar KV; Wang XD; Notarangelo FM; Wu HQ; Schwarcz R
    J Neurochem; 2012 Mar; 120(6):1026-35. PubMed ID: 22224417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early developmental elevations of brain kynurenic acid impair cognitive flexibility in adults: reversal with galantamine.
    Alexander KS; Pocivavsek A; Wu HQ; Pershing ML; Schwarcz R; Bruno JP
    Neuroscience; 2013 May; 238():19-28. PubMed ID: 23395862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of kynurenic acid in brains of genetically dystonic hamsters.
    Richter A; Loscher W; Baran H; Gramer M
    Brain Res Dev Brain Res; 1996 Mar; 92(1):111-6. PubMed ID: 8861729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
    Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
    Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.